Effect of Memo®, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 975-981

  Yakoot, Mostafa ^a   Salem, Amel ^b   Helmy, Sherine ^c  

^a Green Clinic and Research Centre   (Egypt)

^b Mabarrah Clinics   (Egypt)

^c Pharco Pharmaceutical Co   (Egypt)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Mini Mental State Examination; Vascular dementia

Indexed keywords

FLAVONOID; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCOSIDE; MEMO; PLACEBO; ROYAL JELLY; TERPENOID; UNCLASSIFIED DRUG; DRUG COMBINATION; FATTY ACID;

ADULT; AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DSM-IV-TR; DYSPEPSIA; EDUCATIONAL STATUS; EGYPT; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SIDE EFFECT; STUDENT T TEST; TRANSIENT HEADACHE; DRUG COMBINATION; FREEZE DRYING; GINKGO BILOBA; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PANAX; PHYTOTHERAPY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; EGYPT; FATTY ACIDS; FEMALE; FREEZE DRYING; GINKGO BILOBA; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PANAX; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 84880742236     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S44777     Document Type: Article

References (38)

1. Rockwood K, Bowler J, Erkinjuntti T, Hachinski V, Wallin A. Subtypes of vascular dementia. Alzheimer Dis Assoc Disord. 1999;13 Suppl 3: S59-S65.
2. Loeb C, Meyer JS. Vascular dementia: still a debatable entity? J Neurol Sci. 1996;143:31-40.
3. Erkinjuntti T. Vascular dementia: an overview. In: O'Brien J, Bruns L, editors. Dementia, 2nd ed. London, UK: Arnold Press; 2000.
4. Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23-30.
5. Chui H. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone. 2001;3:40-51.
6. Erkinjuntti T. Types of multi-infarct dementia. Acta Neurol Scand. 1987;75:391-399.
7. Cummings JL. Vascular subcortical dementias: clinical aspects. Dementia. 1994;5:177-180.
8. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia. 1994;5:145-147.
9. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology. 1998;17:2-9.
10. Meyer JS, Rogers RL, McClintic K, Mortel KF, Lotfi J. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia: a pilot study. J Am Geriatr Soc. 1989;37:549-555.
11. Li Y, Meyer JS, Haque MA, Chowdhury MH, Hinh P, Quach M. Feasibility of vascular dementia treatment with cholinesterase inhibitors. Int J Geriatr Psychiatry. 2002;17:194-196.
12. Meyer JS, Xu G, Thornby J, Chowdhury MH, Quach M. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke. 2002;33:1981-1985.
13. Wollen KA. Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev. 2010;15:223-244.
14. Guidetti C, Paracchini S, Lucchini S, Cambieri M, Marzatico F. Prevention of neuronal cell damage induced by oxidative stress in vitro: effect of different Ginkgo biloba extracts. J Pharm Pharmacol. 2001;53:387-392.
15. Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca-loaded brain neurons. Brain Res. 1994;635:125-129.
16. Tendi EA, Bosetti F, Dasgupta SF, Stella AM, Drieu K, Rapoport SI. Ginkgo biloba extracts EGB 761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochem Res. 2002;27:319-329.
17. Rapin JR, Lamproglou I, Drieu K, DeFeudis FV. Demonstration of the anti-stress activity of an extract of Ginkgo biloba (EGB 761) using a discrimination learning task. Gen Pharmacol. 1994;25:1009-1016.
18. Ni Y, Zhao B, Hou J, Xin W. Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci Lett. 1996;214:115-118.
19. Porsolt RD, Martin P, Lenègre A, Fromage S, Drieu K. Effects of an extract of Ginkgo biloba (EGB 761) on "learned helplessness" and other models of stress in rodents. Pharmacol Biochem Behav. 1990;36: 963-971.
20. Smith PF, Maclennan L, Darlington CL. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet activating factor (PAF). J Ethnopharmacol. 1996;50:131-139.
21. Clostre F. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. Ann Pharm Fr. 1999;57 Suppl 1:S18-S88. French.
22. Curtis-Prior P, Vere D, Fray P. Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol. 1999;51:535-541.
23. Hoyer S, Lannert H, Nöldner M, Chatterjee SS. Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761). J Neural Transm. 1999;106:1171-1188.
24. Kanowski S, Herrmann WM, Stephan K, Wierich W, Hörr R. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 1996;29:47-56.
25. Ramassamy C, Naudin B, Christen Y, et al. Ginkgo biloba extract EGB 761 or Trolax C prevent ascorbic acid/Fe-induced decrease in synaptasomal membrane fluidity. Free Radical Res. 1993;19: 395-4401.
26. Muller WE. Nootropics, the therapy of dementia between aspiration and reality. Drug News Perspect. 1989;2:295-300.
27. Itil T, Martorano D. Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmacol Bull. 1995;31:147-158.
28. Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res. 1996;57:959-968.
29. Ni X-H, Ohta H, Watanabe H, Mastsumoto K. Panax ginseng extract improves scopolamine-induced deficits in working memory performance in the T-maze delayed alternation task in rats. Phytother Res. 1993;7:49-52.
30. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S. Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro. Biomed Res. 2007;5:261-266.
31. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S. AMP N1-oxide potentiates astrogenesis by cultured neural stem/progenitor cells through STAT3 activation. Biomed Res. 2008;6:295-299.
32. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S. AMP N(1)-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase. Evid Based Complement Alternat Med. 2010;7:63-68.
33. Hattori N, Ohta S, Sakamoto T, Mishima S, Furukawa S. Royal jelly facilitates restoration of the cognitive ability in trimethyltin-intoxicated mice. Evid Based Complement Alternat Med. 2011;2011:165968.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
35. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
36. Wesnes KA, Ward T, Petrini O, McGinty A. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle aged volunteers. Psychopharmacology. 2000;152:353-336.
37. Kennedy DO, Scholey AB, Wesnes KA. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav. 2002;75:739-751.
38. Morita H, Ikeda T, Kajita K, et al. Effect of royal jelly ingestion for six months on healthy volunteers. Nutr J. 2012;11:77.